Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 28, 2020

View Archived Issues

AD and HHV: Still a mystery

Glial cells contribute to brain control of aging

New phase III trial evaluates MK-6482 in advanced renal cell carcinoma

Genetic removal of mast cell Tph1 protects mice from developing obesity and insulin resistance

FDA approves Dificid for C. difficile infection in children age 6 months and older

FDA clears NeoImmuneTech's IND to study NT-I7 plus pembrolizumab in advanced solid tumors

Otsuka reports promising topline data from Japanese trials of fremanezumab in migraine

LNA-anti-miR-150 ameliorates FSGS in vivo

Targeting SK1 overcomes resistance to immune checkpoint inhibitors in melanoma

Retinoic X receptor as therapeutic target for poststroke recovery

Vallon Pharmaceuitcals presents results on manipulated dextroamphetamine sulfate

New hydroxyacid oxidase 1 inhibitors discovered at Orfan Biotech

Gilead describes new IDO-1 inhibitors

Novartis Inflammasome Research describes new NLRP3 inflammasome inhibitors

New CRLF2 ligands identified at Korea University Research and Business Foundation

GeoVax and BravoVax sign letter of intent to codevelop 2019-nCoV coronavirus vaccine

FDA approves Trijardy XR for type 2 diabetes

miR-3064-5p found to have prognostic value in HCC

PULSAR trial of sotatercept in pulmonary arterial hypertension meets primary endpoint

Sichuan Kelun-Biotech Biopharmaceutical discloses RORC agonists

FDA clears INDs for Surface Oncology's antibody candidates SRF-617 and SRF-388

Study suggests direct amino acid toxicity could account for caloric restriction benefits

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.